nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—PTGS2—Triamcinolone—allergic rhinitis	0.0796	0.109	CbGbCtD
Pomalidomide—CYP1A2—Desloratadine—allergic rhinitis	0.0754	0.103	CbGbCtD
Pomalidomide—PTGS2—Betamethasone—allergic rhinitis	0.0683	0.0936	CbGbCtD
Pomalidomide—ABCB1—Desloratadine—allergic rhinitis	0.066	0.0904	CbGbCtD
Pomalidomide—CYP1A2—Diphenhydramine—allergic rhinitis	0.0433	0.0594	CbGbCtD
Pomalidomide—PTGS2—Dexamethasone—allergic rhinitis	0.0397	0.0545	CbGbCtD
Pomalidomide—CYP3A4—Flunisolide—allergic rhinitis	0.0395	0.0542	CbGbCtD
Pomalidomide—ABCB1—Loratadine—allergic rhinitis	0.0379	0.0519	CbGbCtD
Pomalidomide—CYP3A4—Olopatadine—allergic rhinitis	0.0372	0.0509	CbGbCtD
Pomalidomide—ABCB1—Methylprednisolone—allergic rhinitis	0.0347	0.0475	CbGbCtD
Pomalidomide—CYP3A4—Loratadine—allergic rhinitis	0.0227	0.0311	CbGbCtD
Pomalidomide—CYP3A4—Montelukast—allergic rhinitis	0.0227	0.0311	CbGbCtD
Pomalidomide—ABCB1—Betamethasone—allergic rhinitis	0.0225	0.0309	CbGbCtD
Pomalidomide—ABCB1—Prednisolone—allergic rhinitis	0.0222	0.0305	CbGbCtD
Pomalidomide—ABCB1—Hydrocortisone—allergic rhinitis	0.0211	0.0289	CbGbCtD
Pomalidomide—CYP3A4—Methylprednisolone—allergic rhinitis	0.0208	0.0285	CbGbCtD
Pomalidomide—CYP3A4—Triamcinolone—allergic rhinitis	0.0157	0.0216	CbGbCtD
Pomalidomide—CYP3A4—Betamethasone—allergic rhinitis	0.0135	0.0185	CbGbCtD
Pomalidomide—CYP3A4—Prednisolone—allergic rhinitis	0.0133	0.0183	CbGbCtD
Pomalidomide—ABCB1—Dexamethasone—allergic rhinitis	0.0131	0.018	CbGbCtD
Pomalidomide—CYP3A4—Hydrocortisone—allergic rhinitis	0.0126	0.0173	CbGbCtD
Pomalidomide—Thalidomide—NFKB1—allergic rhinitis	0.00903	1	CrCbGaD
Pomalidomide—CYP3A4—Dexamethasone—allergic rhinitis	0.00785	0.0108	CbGbCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL15—allergic rhinitis	0.00226	0.0494	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL13—allergic rhinitis	0.00159	0.0348	CbGpPWpGaD
Pomalidomide—TNF—Type II diabetes mellitus—ADIPOQ—allergic rhinitis	0.00155	0.034	CbGpPWpGaD
Pomalidomide—TNF—Transcription factor regulation in adipogenesis—ADIPOQ—allergic rhinitis	0.00155	0.034	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—IL17A—allergic rhinitis	0.00151	0.033	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL5—allergic rhinitis	0.00136	0.0298	CbGpPWpGaD
Pomalidomide—PTGS2—Fluocinonide—Flunisolide—allergic rhinitis	0.0012	0.213	CbGdCrCtD
Pomalidomide—TNF—IL23-mediated signaling events—IL17A—allergic rhinitis	0.00114	0.0249	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.00114	0.0248	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL10—allergic rhinitis	0.000996	0.0218	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL4—allergic rhinitis	0.000969	0.0212	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.000881	0.0192	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000832	0.0182	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—FOXP3—allergic rhinitis	0.000789	0.0172	CbGpPWpGaD
Pomalidomide—PTGS2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.000724	0.129	CbGdCrCtD
Pomalidomide—TNF—Allograft Rejection—HLA-G—allergic rhinitis	0.000716	0.0156	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.000703	0.0154	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.000688	0.015	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL13—allergic rhinitis	0.000675	0.0147	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—ICAM1—allergic rhinitis	0.000672	0.0147	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL17A—allergic rhinitis	0.000621	0.0136	CbGpPWpGaD
Pomalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000592	0.0129	CbGpPWpGaD
Pomalidomide—PTGS2—Fluocinonide—Methylprednisolone—allergic rhinitis	0.000587	0.104	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Dexamethasone—allergic rhinitis	0.000578	0.103	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Betamethasone—allergic rhinitis	0.000578	0.103	CbGdCrCtD
Pomalidomide—TNF—Allograft Rejection—IL5—allergic rhinitis	0.000577	0.0126	CbGpPWpGaD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—ADIPOQ—allergic rhinitis	0.000571	0.0125	CbGpPWpGaD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000566	0.0124	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—CD4—allergic rhinitis	0.000566	0.0124	CbGpPWpGaD
Pomalidomide—PTGS2—Fluocinonide—Triamcinolone—allergic rhinitis	0.000565	0.1	CbGdCrCtD
Pomalidomide—TNF—Canonical NF-kappaB pathway—NFKB1—allergic rhinitis	0.000554	0.0121	CbGpPWpGaD
Pomalidomide—TNF—EBV LMP1 signaling—NFKB1—allergic rhinitis	0.000554	0.0121	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—SMAD3—allergic rhinitis	0.000551	0.012	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PFN2—allergic rhinitis	0.000533	0.0116	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000515	0.0112	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL4—allergic rhinitis	0.000474	0.0104	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000463	0.0101	CbGpPWpGaD
Pomalidomide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.000458	0.01	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000447	0.00976	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—CD4—allergic rhinitis	0.00044	0.0096	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—NFKB1—allergic rhinitis	0.000426	0.00929	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL10—allergic rhinitis	0.000422	0.00922	CbGpPWpGaD
Pomalidomide—TNF—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—allergic rhinitis	0.000419	0.00914	CbGpPWpGaD
Pomalidomide—TNF—IL27-mediated signaling events—TGFB1—allergic rhinitis	0.000419	0.00914	CbGpPWpGaD
Pomalidomide—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—NFKB1—allergic rhinitis	0.000415	0.00907	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL4—allergic rhinitis	0.000411	0.00897	CbGpPWpGaD
Pomalidomide—TNF—Cytokines and Inflammatory Response—TGFB1—allergic rhinitis	0.000406	0.00887	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL13—allergic rhinitis	0.000391	0.00855	CbGpPWpGaD
Pomalidomide—Decreased appetite—Cetirizine—allergic rhinitis	0.000391	0.00186	CcSEcCtD
Pomalidomide—Dermatitis—Dimenhydrinate—allergic rhinitis	0.000391	0.00186	CcSEcCtD
Pomalidomide—Dermatitis—Diphenhydramine—allergic rhinitis	0.000391	0.00186	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—allergic rhinitis	0.000391	0.00186	CcSEcCtD
Pomalidomide—Cardiac failure congestive—Betamethasone—allergic rhinitis	0.00039	0.00186	CcSEcCtD
Pomalidomide—Cardiac failure congestive—Dexamethasone—allergic rhinitis	0.00039	0.00186	CcSEcCtD
Pomalidomide—Dry skin—Prednisolone—allergic rhinitis	0.000389	0.00185	CcSEcCtD
Pomalidomide—Headache—Diphenhydramine—allergic rhinitis	0.000389	0.00185	CcSEcCtD
Pomalidomide—Headache—Dimenhydrinate—allergic rhinitis	0.000389	0.00185	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Cetirizine—allergic rhinitis	0.000388	0.00185	CcSEcCtD
Pomalidomide—Fatigue—Cetirizine—allergic rhinitis	0.000388	0.00184	CcSEcCtD
Pomalidomide—Constipation—Cetirizine—allergic rhinitis	0.000385	0.00183	CcSEcCtD
Pomalidomide—Pain—Cetirizine—allergic rhinitis	0.000385	0.00183	CcSEcCtD
Pomalidomide—Decreased appetite—Flunisolide—allergic rhinitis	0.000384	0.00183	CcSEcCtD
Pomalidomide—Fatigue—Flunisolide—allergic rhinitis	0.000381	0.00181	CcSEcCtD
Pomalidomide—Dry skin—Hydrocortisone—allergic rhinitis	0.00038	0.00181	CcSEcCtD
Pomalidomide—TNF—IL23-mediated signaling events—NFKB1—allergic rhinitis	0.000379	0.00827	CbGpPWpGaD
Pomalidomide—Pain—Flunisolide—allergic rhinitis	0.000378	0.0018	CcSEcCtD
Pomalidomide—Constipation—Flunisolide—allergic rhinitis	0.000378	0.0018	CcSEcCtD
Pomalidomide—Body temperature increased—Loratadine—allergic rhinitis	0.000378	0.0018	CcSEcCtD
Pomalidomide—Hypokalaemia—Hydrocortisone—allergic rhinitis	0.000377	0.00179	CcSEcCtD
Pomalidomide—Nausea—Olopatadine—allergic rhinitis	0.000377	0.00179	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—ICAM1—allergic rhinitis	0.000377	0.00823	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—ADIPOQ—allergic rhinitis	0.000375	0.0082	CbGpPWpGaD
Pomalidomide—Infection—Montelukast—allergic rhinitis	0.000375	0.00178	CcSEcCtD
Pomalidomide—Muscular weakness—Prednisolone—allergic rhinitis	0.000374	0.00178	CcSEcCtD
Pomalidomide—Feeling abnormal—Cetirizine—allergic rhinitis	0.000371	0.00176	CcSEcCtD
Pomalidomide—Nervous system disorder—Montelukast—allergic rhinitis	0.00037	0.00176	CcSEcCtD
Pomalidomide—Thrombocytopenia—Montelukast—allergic rhinitis	0.000369	0.00176	CcSEcCtD
Pomalidomide—Nausea—Dimenhydrinate—allergic rhinitis	0.000369	0.00175	CcSEcCtD
Pomalidomide—Nausea—Diphenhydramine—allergic rhinitis	0.000369	0.00175	CcSEcCtD
Pomalidomide—Skin disorder—Montelukast—allergic rhinitis	0.000366	0.00174	CcSEcCtD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	0.000366	0.008	CbGpPWpGaD
Pomalidomide—Alanine aminotransferase increased—Hydrocortisone—allergic rhinitis	0.000365	0.00174	CcSEcCtD
Pomalidomide—Muscular weakness—Hydrocortisone—allergic rhinitis	0.000365	0.00174	CcSEcCtD
Pomalidomide—Feeling abnormal—Flunisolide—allergic rhinitis	0.000364	0.00173	CcSEcCtD
Pomalidomide—TNF—SIDS Susceptibility Pathways—TAC1—allergic rhinitis	0.00036	0.00787	CbGpPWpGaD
Pomalidomide—Body temperature increased—Cetirizine—allergic rhinitis	0.000356	0.00169	CcSEcCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	0.000354	0.063	CbGdCrCtD
Pomalidomide—Breast disorder—Methylprednisolone—allergic rhinitis	0.000352	0.00167	CcSEcCtD
Pomalidomide—Body temperature increased—Flunisolide—allergic rhinitis	0.00035	0.00166	CcSEcCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Betamethasone—allergic rhinitis	0.000349	0.062	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	0.000349	0.062	CbGdCrCtD
Pomalidomide—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.000346	0.00755	CbGpPWpGaD
Pomalidomide—Muscular weakness—Triamcinolone—allergic rhinitis	0.000344	0.00164	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000344	0.00163	CcSEcCtD
Pomalidomide—Muscular weakness—Methylprednisolone—allergic rhinitis	0.000343	0.00163	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Methylprednisolone—allergic rhinitis	0.000343	0.00163	CcSEcCtD
Pomalidomide—Asthenia—Loratadine—allergic rhinitis	0.000343	0.00163	CcSEcCtD
Pomalidomide—TNF—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	0.000342	0.00748	CbGpPWpGaD
Pomalidomide—Insomnia—Montelukast—allergic rhinitis	0.000341	0.00162	CcSEcCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	0.000341	0.0606	CbGdCrCtD
Pomalidomide—Weight increased—Prednisolone—allergic rhinitis	0.000334	0.00159	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Hydrocortisone—allergic rhinitis	0.000333	0.00158	CcSEcCtD
Pomalidomide—Hypersensitivity—Cetirizine—allergic rhinitis	0.000331	0.00158	CcSEcCtD
Pomalidomide—Diarrhoea—Loratadine—allergic rhinitis	0.000327	0.00156	CcSEcCtD
Pomalidomide—Weight increased—Hydrocortisone—allergic rhinitis	0.000326	0.00155	CcSEcCtD
Pomalidomide—Hypersensitivity—Flunisolide—allergic rhinitis	0.000326	0.00155	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Montelukast—allergic rhinitis	0.000326	0.00155	CcSEcCtD
Pomalidomide—Fatigue—Montelukast—allergic rhinitis	0.000325	0.00155	CcSEcCtD
Pomalidomide—Dry skin—Betamethasone—allergic rhinitis	0.000325	0.00154	CcSEcCtD
Pomalidomide—Dry skin—Dexamethasone—allergic rhinitis	0.000325	0.00154	CcSEcCtD
Pomalidomide—Bronchitis—Triamcinolone—allergic rhinitis	0.000324	0.00154	CcSEcCtD
Pomalidomide—Weight decreased—Hydrocortisone—allergic rhinitis	0.000324	0.00154	CcSEcCtD
Pomalidomide—Asthenia—Cetirizine—allergic rhinitis	0.000323	0.00154	CcSEcCtD
Pomalidomide—Pain—Montelukast—allergic rhinitis	0.000323	0.00153	CcSEcCtD
Pomalidomide—Hypokalaemia—Betamethasone—allergic rhinitis	0.000322	0.00153	CcSEcCtD
Pomalidomide—Hypokalaemia—Dexamethasone—allergic rhinitis	0.000322	0.00153	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Prednisolone—allergic rhinitis	0.000321	0.00152	CcSEcCtD
Pomalidomide—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000319	0.00152	CcSEcCtD
Pomalidomide—Infestation—Hydrocortisone—allergic rhinitis	0.000319	0.00152	CcSEcCtD
Pomalidomide—TNF—TNF receptor signaling pathway —NFKB1—allergic rhinitis	0.000318	0.00695	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000318	0.00695	CbGpPWpGaD
Pomalidomide—Pruritus—Cetirizine—allergic rhinitis	0.000318	0.00151	CcSEcCtD
Pomalidomide—Asthenia—Flunisolide—allergic rhinitis	0.000317	0.00151	CcSEcCtD
Pomalidomide—Dizziness—Loratadine—allergic rhinitis	0.000316	0.0015	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000314	0.00686	CbGpPWpGaD
Pomalidomide—Upper respiratory tract infection—Triamcinolone—allergic rhinitis	0.000313	0.00149	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Hydrocortisone—allergic rhinitis	0.000313	0.00149	CcSEcCtD
Pomalidomide—Pruritus—Flunisolide—allergic rhinitis	0.000313	0.00149	CcSEcCtD
Pomalidomide—Muscular weakness—Dexamethasone—allergic rhinitis	0.000312	0.00149	CcSEcCtD
Pomalidomide—Muscular weakness—Betamethasone—allergic rhinitis	0.000312	0.00149	CcSEcCtD
Pomalidomide—Diarrhoea—Cetirizine—allergic rhinitis	0.000308	0.00146	CcSEcCtD
Pomalidomide—TNF—Ceramide signaling pathway—NFKB1—allergic rhinitis	0.000308	0.00672	CbGpPWpGaD
Pomalidomide—Weight increased—Triamcinolone—allergic rhinitis	0.000307	0.00146	CcSEcCtD
Pomalidomide—Weight increased—Methylprednisolone—allergic rhinitis	0.000306	0.00146	CcSEcCtD
Pomalidomide—Vomiting—Loratadine—allergic rhinitis	0.000304	0.00145	CcSEcCtD
Pomalidomide—Diarrhoea—Flunisolide—allergic rhinitis	0.000303	0.00144	CcSEcCtD
Pomalidomide—Rash—Loratadine—allergic rhinitis	0.000301	0.00143	CcSEcCtD
Pomalidomide—Dermatitis—Loratadine—allergic rhinitis	0.000301	0.00143	CcSEcCtD
Pomalidomide—Infestation—Methylprednisolone—allergic rhinitis	0.0003	0.00143	CcSEcCtD
Pomalidomide—Infestation NOS—Methylprednisolone—allergic rhinitis	0.0003	0.00143	CcSEcCtD
Pomalidomide—Headache—Loratadine—allergic rhinitis	0.000299	0.00142	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000299	0.00653	CbGpPWpGaD
Pomalidomide—Body temperature increased—Montelukast—allergic rhinitis	0.000298	0.00142	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—IL4—allergic rhinitis	0.000298	0.0065	CbGpPWpGaD
Pomalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	0.000298	0.0065	CbGpPWpGaD
Pomalidomide—Dizziness—Cetirizine—allergic rhinitis	0.000297	0.00142	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000296	0.00646	CbGpPWpGaD
Pomalidomide—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.000295	0.0014	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.000294	0.0014	CcSEcCtD
Pomalidomide—TNF—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	0.000293	0.0064	CbGpPWpGaD
Pomalidomide—Dizziness—Flunisolide—allergic rhinitis	0.000292	0.00139	CcSEcCtD
Pomalidomide—Vomiting—Cetirizine—allergic rhinitis	0.000286	0.00136	CcSEcCtD
Pomalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—allergic rhinitis	0.000284	0.00621	CbGpPWpGaD
Pomalidomide—Nausea—Loratadine—allergic rhinitis	0.000284	0.00135	CcSEcCtD
Pomalidomide—Epistaxis—Triamcinolone—allergic rhinitis	0.000284	0.00135	CcSEcCtD
Pomalidomide—Rash—Cetirizine—allergic rhinitis	0.000284	0.00135	CcSEcCtD
Pomalidomide—Dermatitis—Cetirizine—allergic rhinitis	0.000283	0.00135	CcSEcCtD
Pomalidomide—Headache—Cetirizine—allergic rhinitis	0.000282	0.00134	CcSEcCtD
Pomalidomide—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000282	0.00134	CcSEcCtD
Pomalidomide—Vomiting—Flunisolide—allergic rhinitis	0.000281	0.00134	CcSEcCtD
Pomalidomide—TNF—TGF-beta Receptor Signaling—NFKB1—allergic rhinitis	0.00028	0.00611	CbGpPWpGaD
Pomalidomide—Rash—Flunisolide—allergic rhinitis	0.000279	0.00133	CcSEcCtD
Pomalidomide—Dermatitis—Flunisolide—allergic rhinitis	0.000279	0.00133	CcSEcCtD
Pomalidomide—Weight increased—Dexamethasone—allergic rhinitis	0.000278	0.00132	CcSEcCtD
Pomalidomide—Weight increased—Betamethasone—allergic rhinitis	0.000278	0.00132	CcSEcCtD
Pomalidomide—Hypersensitivity—Montelukast—allergic rhinitis	0.000278	0.00132	CcSEcCtD
Pomalidomide—Headache—Flunisolide—allergic rhinitis	0.000277	0.00132	CcSEcCtD
Pomalidomide—Weight decreased—Betamethasone—allergic rhinitis	0.000277	0.00132	CcSEcCtD
Pomalidomide—Weight decreased—Dexamethasone—allergic rhinitis	0.000277	0.00132	CcSEcCtD
Pomalidomide—Hyperglycaemia—Betamethasone—allergic rhinitis	0.000276	0.00131	CcSEcCtD
Pomalidomide—Hyperglycaemia—Dexamethasone—allergic rhinitis	0.000276	0.00131	CcSEcCtD
Pomalidomide—TNF—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000276	0.00603	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—SMAD3—allergic rhinitis	0.000273	0.00596	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.000272	0.00595	CbGpPWpGaD
Pomalidomide—Asthenia—Montelukast—allergic rhinitis	0.000271	0.00129	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000267	0.00127	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000267	0.00127	CcSEcCtD
Pomalidomide—Nausea—Cetirizine—allergic rhinitis	0.000267	0.00127	CcSEcCtD
Pomalidomide—Pruritus—Montelukast—allergic rhinitis	0.000267	0.00127	CcSEcCtD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000265	0.00579	CbGpPWpGaD
Pomalidomide—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000265	0.00126	CcSEcCtD
Pomalidomide—Nausea—Flunisolide—allergic rhinitis	0.000263	0.00125	CcSEcCtD
Pomalidomide—Diarrhoea—Montelukast—allergic rhinitis	0.000258	0.00123	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000253	0.00553	CbGpPWpGaD
Pomalidomide—Mental disorder—Hydrocortisone—allergic rhinitis	0.000251	0.00119	CcSEcCtD
Pomalidomide—Cardiac disorder—Methylprednisolone—allergic rhinitis	0.00025	0.00119	CcSEcCtD
Pomalidomide—Malnutrition—Hydrocortisone—allergic rhinitis	0.00025	0.00119	CcSEcCtD
Pomalidomide—Dizziness—Montelukast—allergic rhinitis	0.000249	0.00119	CcSEcCtD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL10—allergic rhinitis	0.000245	0.00535	CbGpPWpGaD
Pomalidomide—Angiopathy—Methylprednisolone—allergic rhinitis	0.000244	0.00116	CcSEcCtD
Pomalidomide—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000243	0.00115	CcSEcCtD
Pomalidomide—Vomiting—Montelukast—allergic rhinitis	0.00024	0.00114	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—NFKB1—allergic rhinitis	0.000238	0.00521	CbGpPWpGaD
Pomalidomide—Rash—Montelukast—allergic rhinitis	0.000238	0.00113	CcSEcCtD
Pomalidomide—Dermatitis—Montelukast—allergic rhinitis	0.000238	0.00113	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000237	0.00517	CbGpPWpGaD
Pomalidomide—Headache—Montelukast—allergic rhinitis	0.000236	0.00112	CcSEcCtD
Pomalidomide—Mental disorder—Methylprednisolone—allergic rhinitis	0.000236	0.00112	CcSEcCtD
Pomalidomide—Malnutrition—Methylprednisolone—allergic rhinitis	0.000234	0.00112	CcSEcCtD
Pomalidomide—TNF—TGF-beta Receptor Signaling—TGFB1—allergic rhinitis	0.000233	0.00509	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.00023	0.00502	CbGpPWpGaD
Pomalidomide—Vertigo—Prednisolone—allergic rhinitis	0.00023	0.00109	CcSEcCtD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—NFKB1—allergic rhinitis	0.000228	0.00497	CbGpPWpGaD
Pomalidomide—Back pain—Triamcinolone—allergic rhinitis	0.000227	0.00108	CcSEcCtD
Pomalidomide—Vertigo—Hydrocortisone—allergic rhinitis	0.000224	0.00107	CcSEcCtD
Pomalidomide—Nausea—Montelukast—allergic rhinitis	0.000224	0.00107	CcSEcCtD
Pomalidomide—Angiopathy—Dexamethasone—allergic rhinitis	0.000222	0.00106	CcSEcCtD
Pomalidomide—Angiopathy—Betamethasone—allergic rhinitis	0.000222	0.00106	CcSEcCtD
Pomalidomide—Anxiety—Hydrocortisone—allergic rhinitis	0.000212	0.00101	CcSEcCtD
Pomalidomide—Vertigo—Triamcinolone—allergic rhinitis	0.000211	0.001	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000211	0.001	CcSEcCtD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—allergic rhinitis	0.000211	0.0046	CbGpPWpGaD
Pomalidomide—Vertigo—Methylprednisolone—allergic rhinitis	0.000211	0.001	CcSEcCtD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000206	0.00449	CbGpPWpGaD
Pomalidomide—Cough—Triamcinolone—allergic rhinitis	0.000205	0.000976	CcSEcCtD
Pomalidomide—Infection—Hydrocortisone—allergic rhinitis	0.000202	0.000963	CcSEcCtD
Pomalidomide—Hyperhidrosis—Prednisolone—allergic rhinitis	0.000202	0.000959	CcSEcCtD
Pomalidomide—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.0002	0.00095	CcSEcCtD
Pomalidomide—Arthralgia—Methylprednisolone—allergic rhinitis	0.0002	0.00095	CcSEcCtD
Pomalidomide—Anxiety—Methylprednisolone—allergic rhinitis	0.000199	0.000946	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000198	0.000943	CcSEcCtD
Pomalidomide—Skin disorder—Hydrocortisone—allergic rhinitis	0.000198	0.000941	CcSEcCtD
Pomalidomide—Hyperhidrosis—Hydrocortisone—allergic rhinitis	0.000197	0.000937	CcSEcCtD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000197	0.0043	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000197	0.00429	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—NFKB1—allergic rhinitis	0.000197	0.00429	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	0.000196	0.00428	CbGpPWpGaD
Pomalidomide—Confusional state—Methylprednisolone—allergic rhinitis	0.000193	0.000918	CcSEcCtD
Pomalidomide—Vertigo—Dexamethasone—allergic rhinitis	0.000192	0.000911	CcSEcCtD
Pomalidomide—Vertigo—Betamethasone—allergic rhinitis	0.000192	0.000911	CcSEcCtD
Pomalidomide—Infection—Triamcinolone—allergic rhinitis	0.000191	0.000906	CcSEcCtD
Pomalidomide—Infection—Methylprednisolone—allergic rhinitis	0.00019	0.000904	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000189	0.00414	CbGpPWpGaD
Pomalidomide—Insomnia—Prednisolone—allergic rhinitis	0.000189	0.000897	CcSEcCtD
Pomalidomide—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000188	0.000893	CcSEcCtD
Pomalidomide—Skin disorder—Methylprednisolone—allergic rhinitis	0.000186	0.000884	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000186	0.000883	CcSEcCtD
Pomalidomide—Hyperhidrosis—Triamcinolone—allergic rhinitis	0.000185	0.000882	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	0.000185	0.00404	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL10—allergic rhinitis	0.000185	0.00404	CbGpPWpGaD
Pomalidomide—Hyperhidrosis—Methylprednisolone—allergic rhinitis	0.000185	0.00088	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—IL4—allergic rhinitis	0.000184	0.00402	CbGpPWpGaD
Pomalidomide—Insomnia—Hydrocortisone—allergic rhinitis	0.000184	0.000876	CcSEcCtD
Pomalidomide—TNF—TNF alpha Signaling Pathway—NFKB1—allergic rhinitis	0.000183	0.00399	CbGpPWpGaD
Pomalidomide—Anxiety—Betamethasone—allergic rhinitis	0.000181	0.000861	CcSEcCtD
Pomalidomide—Anxiety—Dexamethasone—allergic rhinitis	0.000181	0.000861	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—IL4—allergic rhinitis	0.00018	0.00393	CbGpPWpGaD
Pomalidomide—Pain—Prednisolone—allergic rhinitis	0.000178	0.000848	CcSEcCtD
Pomalidomide—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000177	0.000842	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000176	0.000837	CcSEcCtD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—allergic rhinitis	0.000176	0.00383	CbGpPWpGaD
Pomalidomide—Fatigue—Hydrocortisone—allergic rhinitis	0.000176	0.000835	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000175	0.000831	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000174	0.000829	CcSEcCtD
Pomalidomide—Pain—Hydrocortisone—allergic rhinitis	0.000174	0.000829	CcSEcCtD
Pomalidomide—Insomnia—Triamcinolone—allergic rhinitis	0.000173	0.000825	CcSEcCtD
Pomalidomide—Insomnia—Methylprednisolone—allergic rhinitis	0.000173	0.000823	CcSEcCtD
Pomalidomide—Infection—Dexamethasone—allergic rhinitis	0.000173	0.000822	CcSEcCtD
Pomalidomide—Infection—Betamethasone—allergic rhinitis	0.000173	0.000822	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—TGFB1—allergic rhinitis	0.000172	0.00376	CbGpPWpGaD
Pomalidomide—Feeling abnormal—Prednisolone—allergic rhinitis	0.000172	0.000818	CcSEcCtD
Pomalidomide—Dyspnoea—Triamcinolone—allergic rhinitis	0.000171	0.000813	CcSEcCtD
Pomalidomide—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000171	0.000812	CcSEcCtD
Pomalidomide—Nervous system disorder—Betamethasone—allergic rhinitis	0.000171	0.000812	CcSEcCtD
Pomalidomide—Thrombocytopenia—Betamethasone—allergic rhinitis	0.00017	0.000811	CcSEcCtD
Pomalidomide—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.00017	0.000811	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	0.000168	0.00368	CbGpPWpGaD
Pomalidomide—Hyperhidrosis—Dexamethasone—allergic rhinitis	0.000168	0.0008	CcSEcCtD
Pomalidomide—Hyperhidrosis—Betamethasone—allergic rhinitis	0.000168	0.0008	CcSEcCtD
Pomalidomide—Feeling abnormal—Hydrocortisone—allergic rhinitis	0.000168	0.000799	CcSEcCtD
Pomalidomide—Fatigue—Triamcinolone—allergic rhinitis	0.000165	0.000787	CcSEcCtD
Pomalidomide—Fatigue—Methylprednisolone—allergic rhinitis	0.000165	0.000785	CcSEcCtD
Pomalidomide—Pain—Triamcinolone—allergic rhinitis	0.000164	0.00078	CcSEcCtD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.000164	0.00358	CbGpPWpGaD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000161	0.00352	CbGpPWpGaD
Pomalidomide—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000161	0.000766	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000159	0.000754	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000159	0.000754	CcSEcCtD
Pomalidomide—Feeling abnormal—Triamcinolone—allergic rhinitis	0.000158	0.000752	CcSEcCtD
Pomalidomide—Feeling abnormal—Methylprednisolone—allergic rhinitis	0.000158	0.00075	CcSEcCtD
Pomalidomide—Insomnia—Betamethasone—allergic rhinitis	0.000157	0.000749	CcSEcCtD
Pomalidomide—Insomnia—Dexamethasone—allergic rhinitis	0.000157	0.000749	CcSEcCtD
Pomalidomide—Hypersensitivity—Prednisolone—allergic rhinitis	0.000154	0.000731	CcSEcCtD
Pomalidomide—Body temperature increased—Triamcinolone—allergic rhinitis	0.000152	0.000721	CcSEcCtD
Pomalidomide—Decreased appetite—Dexamethasone—allergic rhinitis	0.000151	0.00072	CcSEcCtD
Pomalidomide—Decreased appetite—Betamethasone—allergic rhinitis	0.000151	0.00072	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.00015	0.000715	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.00015	0.000715	CcSEcCtD
Pomalidomide—Hypersensitivity—Hydrocortisone—allergic rhinitis	0.00015	0.000714	CcSEcCtD
Pomalidomide—Fatigue—Dexamethasone—allergic rhinitis	0.00015	0.000714	CcSEcCtD
Pomalidomide—Fatigue—Betamethasone—allergic rhinitis	0.00015	0.000714	CcSEcCtD
Pomalidomide—Pain—Dexamethasone—allergic rhinitis	0.000149	0.000708	CcSEcCtD
Pomalidomide—Pain—Betamethasone—allergic rhinitis	0.000149	0.000708	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000146	0.0032	CbGpPWpGaD
Pomalidomide—Asthenia—Hydrocortisone—allergic rhinitis	0.000146	0.000695	CcSEcCtD
Pomalidomide—Pruritus—Hydrocortisone—allergic rhinitis	0.000144	0.000686	CcSEcCtD
Pomalidomide—Feeling abnormal—Dexamethasone—allergic rhinitis	0.000143	0.000682	CcSEcCtD
Pomalidomide—Feeling abnormal—Betamethasone—allergic rhinitis	0.000143	0.000682	CcSEcCtD
Pomalidomide—Hypersensitivity—Triamcinolone—allergic rhinitis	0.000141	0.000672	CcSEcCtD
Pomalidomide—PTGS2—C-MYB transcription factor network—CD4—allergic rhinitis	0.000141	0.00308	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Methylprednisolone—allergic rhinitis	0.000141	0.000671	CcSEcCtD
Pomalidomide—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000139	0.000663	CcSEcCtD
Pomalidomide—Dizziness—Prednisolone—allergic rhinitis	0.000138	0.000656	CcSEcCtD
Pomalidomide—Asthenia—Triamcinolone—allergic rhinitis	0.000138	0.000655	CcSEcCtD
Pomalidomide—Body temperature increased—Betamethasone—allergic rhinitis	0.000138	0.000654	CcSEcCtD
Pomalidomide—Body temperature increased—Dexamethasone—allergic rhinitis	0.000138	0.000654	CcSEcCtD
Pomalidomide—Asthenia—Methylprednisolone—allergic rhinitis	0.000137	0.000653	CcSEcCtD
Pomalidomide—Pruritus—Triamcinolone—allergic rhinitis	0.000136	0.000646	CcSEcCtD
Pomalidomide—Pruritus—Methylprednisolone—allergic rhinitis	0.000135	0.000644	CcSEcCtD
Pomalidomide—Dizziness—Hydrocortisone—allergic rhinitis	0.000135	0.000641	CcSEcCtD
Pomalidomide—Rash—Prednisolone—allergic rhinitis	0.000131	0.000626	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	0.000131	0.00287	CbGpPWpGaD
Pomalidomide—Dermatitis—Prednisolone—allergic rhinitis	0.000131	0.000625	CcSEcCtD
Pomalidomide—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000131	0.000623	CcSEcCtD
Pomalidomide—Headache—Prednisolone—allergic rhinitis	0.000131	0.000622	CcSEcCtD
Pomalidomide—Vomiting—Hydrocortisone—allergic rhinitis	0.000129	0.000616	CcSEcCtD
Pomalidomide—TNF—Developmental Biology—ADIPOQ—allergic rhinitis	0.000129	0.00282	CbGpPWpGaD
Pomalidomide—Rash—Hydrocortisone—allergic rhinitis	0.000128	0.000611	CcSEcCtD
Pomalidomide—Dermatitis—Hydrocortisone—allergic rhinitis	0.000128	0.00061	CcSEcCtD
Pomalidomide—Headache—Hydrocortisone—allergic rhinitis	0.000128	0.000607	CcSEcCtD
Pomalidomide—Dizziness—Triamcinolone—allergic rhinitis	0.000127	0.000603	CcSEcCtD
Pomalidomide—Dizziness—Methylprednisolone—allergic rhinitis	0.000127	0.000602	CcSEcCtD
Pomalidomide—Asthenia—Dexamethasone—allergic rhinitis	0.000125	0.000594	CcSEcCtD
Pomalidomide—Asthenia—Betamethasone—allergic rhinitis	0.000125	0.000594	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—TGFB1—allergic rhinitis	0.000125	0.00273	CbGpPWpGaD
Pomalidomide—Nausea—Prednisolone—allergic rhinitis	0.000124	0.000589	CcSEcCtD
Pomalidomide—Pruritus—Betamethasone—allergic rhinitis	0.000123	0.000586	CcSEcCtD
Pomalidomide—Pruritus—Dexamethasone—allergic rhinitis	0.000123	0.000586	CcSEcCtD
Pomalidomide—Vomiting—Triamcinolone—allergic rhinitis	0.000122	0.00058	CcSEcCtD
Pomalidomide—Vomiting—Methylprednisolone—allergic rhinitis	0.000122	0.000579	CcSEcCtD
Pomalidomide—Nausea—Hydrocortisone—allergic rhinitis	0.000121	0.000576	CcSEcCtD
Pomalidomide—Rash—Triamcinolone—allergic rhinitis	0.000121	0.000575	CcSEcCtD
Pomalidomide—Dermatitis—Triamcinolone—allergic rhinitis	0.000121	0.000575	CcSEcCtD
Pomalidomide—Rash—Methylprednisolone—allergic rhinitis	0.000121	0.000574	CcSEcCtD
Pomalidomide—Dermatitis—Methylprednisolone—allergic rhinitis	0.000121	0.000573	CcSEcCtD
Pomalidomide—Headache—Triamcinolone—allergic rhinitis	0.00012	0.000572	CcSEcCtD
Pomalidomide—Headache—Methylprednisolone—allergic rhinitis	0.00012	0.00057	CcSEcCtD
Pomalidomide—TNF—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	0.00012	0.00262	CbGpPWpGaD
Pomalidomide—Diarrhoea—Betamethasone—allergic rhinitis	0.000119	0.000566	CcSEcCtD
Pomalidomide—Diarrhoea—Dexamethasone—allergic rhinitis	0.000119	0.000566	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	0.000117	0.00256	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—TGFB1—allergic rhinitis	0.000115	0.00252	CbGpPWpGaD
Pomalidomide—Dizziness—Dexamethasone—allergic rhinitis	0.000115	0.000547	CcSEcCtD
Pomalidomide—Dizziness—Betamethasone—allergic rhinitis	0.000115	0.000547	CcSEcCtD
Pomalidomide—Nausea—Triamcinolone—allergic rhinitis	0.000114	0.000542	CcSEcCtD
Pomalidomide—Nausea—Methylprednisolone—allergic rhinitis	0.000114	0.000541	CcSEcCtD
Pomalidomide—TNF—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000113	0.00247	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000111	0.00243	CbGpPWpGaD
Pomalidomide—Vomiting—Dexamethasone—allergic rhinitis	0.000111	0.000526	CcSEcCtD
Pomalidomide—Vomiting—Betamethasone—allergic rhinitis	0.000111	0.000526	CcSEcCtD
Pomalidomide—Rash—Betamethasone—allergic rhinitis	0.00011	0.000522	CcSEcCtD
Pomalidomide—Rash—Dexamethasone—allergic rhinitis	0.00011	0.000522	CcSEcCtD
Pomalidomide—Dermatitis—Betamethasone—allergic rhinitis	0.00011	0.000522	CcSEcCtD
Pomalidomide—Dermatitis—Dexamethasone—allergic rhinitis	0.00011	0.000522	CcSEcCtD
Pomalidomide—Headache—Dexamethasone—allergic rhinitis	0.000109	0.000519	CcSEcCtD
Pomalidomide—Headache—Betamethasone—allergic rhinitis	0.000109	0.000519	CcSEcCtD
Pomalidomide—Nausea—Dexamethasone—allergic rhinitis	0.000103	0.000492	CcSEcCtD
Pomalidomide—Nausea—Betamethasone—allergic rhinitis	0.000103	0.000492	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	0.000102	0.00223	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TGFB1—allergic rhinitis	9.41e-05	0.00205	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—SMAD3—allergic rhinitis	9.37e-05	0.00205	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	9.28e-05	0.00203	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	8.49e-05	0.00185	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—allergic rhinitis	7.72e-05	0.00169	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	7.54e-05	0.00165	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	6.3e-05	0.00138	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	5.25e-05	0.00115	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NFKB1—allergic rhinitis	4.77e-05	0.00104	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.47e-05	0.000976	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—allergic rhinitis	3.97e-05	0.000867	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.72e-05	0.000813	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SMAD3—allergic rhinitis	2.75e-05	0.000601	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—allergic rhinitis	1.62e-05	0.000355	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—allergic rhinitis	1.17e-05	0.000255	CbGpPWpGaD
